The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis Via Modulating Multiple Signaling Pathways in Mice

Hepatic fibrosis represents an important event in the progression of chronic liver injury to cirrhosis, and is characterized by excessive extracellular matrix proteins aggregation. Early fibrosis can be reversed by inhibiting hepatocyte injury, inflammation, or hepatic stellate cells activation, so...

Descripción completa

Detalles Bibliográficos
Autores principales: Ai, Yongqiang, Shi, Wei, Zuo, Xiaobin, Sun, Xiaoming, Chen, Yuanyuan, Wang, Zhilei, Li, Ruisheng, Song, Xueai, Dai, Wenzhang, Mu, Wenqing, Ding, Kaixin, Li, Zhiyong, Li, Qiang, Xiao, Xiaohe, Zhan, Xiaoyan, Bai, Zhaofang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211319/
https://www.ncbi.nlm.nih.gov/pubmed/34149411
http://dx.doi.org/10.3389/fphar.2021.655531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211319/
https://www.ncbi.nlm.nih.gov/pubmed/34149411
http://dx.doi.org/10.3389/fphar.2021.655531

Ejemplares similares